Drug Stocks Ignoring Obamacare

The healthcare industry is thriving despite Obamacare's rocky rollout, says Terry Hisey, Vice Chairman Healthcare Life Sciences at Deloitte.
Author:
Publish date:

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.